Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

1.7K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.7K
Lineage Commitment01:21

Lineage Commitment

3.9K
Commitment is the  process whereby stem cells:
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex Differences in Depression: Adult Cytogenesis as Potential Target for Precision Psychiatry.

Cells·2026
Same author

Sociodemographic, Clinical, and Therapeutic Characterization of Multiple Myeloma Patients (CharisMMa Study) with Symptomatic Relapse and/or Refractory Disease: An Observational, Multicenter Study in Portugal.

Hematology reports·2026
Same author

Maternal infection in the context of actively managed prelabor rupture of membranes at term: An observational study.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Impact of the 2023 ACR/EULAR classification criteria in pregnant women with primary antiphospholipid syndrome: insights from a Portuguese cohort.

ARP rheumatology·2026
Same author

Adult astrocyte generation across health and disease: A systematic review.

Neural regeneration research·2026
Same author

Refractory Angina with Myocardial Ischemia in the Absence of Obstructive Coronary Artery Disease: A Case Report.

Arquivos brasileiros de cardiologia·2026

Related Experiment Video

Updated: Dec 24, 2025

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.9K

Plasma cell leukaemia.

Carlos Galvão Braga1, Ana Raquel Rodrigues1, Marina Alves1

  • 1Serviço de Medicina Interna, Hospital de Braga, Braga, Portugal.

Porto Biomedical Journal
|April 8, 2020
PubMed
Summary

Plasma cell leukaemia (PCL) is a rare, aggressive cancer. This case report details a 51-year-old man diagnosed with PCL, highlighting the disease

Keywords:
Multiple myelomaPlasma cell leukaemia

More Related Videos

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL
06:41

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL

Published on: July 19, 2024

1.2K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.5K

Related Experiment Videos

Last Updated: Dec 24, 2025

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

12.9K
Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL
06:41

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL

Published on: July 19, 2024

1.2K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.5K

Area of Science:

  • Hematology
  • Oncology

Background:

  • Plasma cell leukaemia (PCL) is a rare and aggressive hematologic malignancy.
  • Diagnosis requires >2000/mL circulating plasma cells or >20% plasmacytosis in leukocytes.
  • PCL carries a dismal prognosis with limited established treatment options.

Purpose of the Study:

  • To report a case of PCL in a 51-year-old male.
  • To illustrate the diagnostic criteria and clinical presentation of PCL.
  • To discuss the challenges in managing PCL and the need for improved therapeutic strategies.

Main Methods:

  • Case report of a 51-year-old male presenting with bone pain and constitutional symptoms.
  • Diagnostic evaluation included peripheral blood smear and bone marrow biopsy.
  • Treatment involved chemotherapy with vincristine, adriamycin, and dexamethasone.

Main Results:

  • Peripheral blood smear showed 39% plasma cells, confirming leukocytosis.
  • Bone marrow biopsy confirmed extensive plasma cell infiltration, establishing the PCL diagnosis.
  • The patient exhibited markers of advanced disease and experienced a fatal infectious complication despite initial treatment response.

Conclusions:

  • PCL is an aggressive disease with a poor prognosis.
  • Current treatment strategies for PCL are limited and require further development.
  • Improved data and novel therapeutic approaches are crucial to enhance outcomes for PCL patients.